Menu
GeneBe

rs34967813

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001035.3(RYR2):c.8873A>G(p.Gln2958Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.264 in 1,596,616 control chromosomes in the GnomAD database, including 62,959 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q2958K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.20 ( 4190 hom., cov: 33)
Exomes 𝑓: 0.27 ( 58769 hom. )

Consequence

RYR2
NM_001035.3 missense

Scores

8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 7.21
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant where missense usually causes diseases, RYR2
BP4
Computational evidence support a benign effect (MetaRNN=0.0015868247).
BP6
Variant 1-237678090-A-G is Benign according to our data. Variant chr1-237678090-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 36750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-237678090-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RYR2NM_001035.3 linkuse as main transcriptc.8873A>G p.Gln2958Arg missense_variant 61/105 ENST00000366574.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RYR2ENST00000366574.7 linkuse as main transcriptc.8873A>G p.Gln2958Arg missense_variant 61/1051 NM_001035.3 P1Q92736-1
RYR2ENST00000660292.2 linkuse as main transcriptc.8873A>G p.Gln2958Arg missense_variant 61/106
RYR2ENST00000659194.3 linkuse as main transcriptc.8873A>G p.Gln2958Arg missense_variant 61/105
RYR2ENST00000609119.2 linkuse as main transcriptc.8831-2366A>G intron_variant, NMD_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30640
AN:
152112
Hom.:
4190
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0537
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.213
Gnomad ASJ
AF:
0.212
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.0760
Gnomad FIN
AF:
0.230
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.309
Gnomad OTH
AF:
0.186
GnomAD3 exomes
AF:
0.214
AC:
51651
AN:
241208
Hom.:
6938
AF XY:
0.214
AC XY:
27961
AN XY:
130522
show subpopulations
Gnomad AFR exome
AF:
0.0483
Gnomad AMR exome
AF:
0.198
Gnomad ASJ exome
AF:
0.222
Gnomad EAS exome
AF:
0.000736
Gnomad SAS exome
AF:
0.0779
Gnomad FIN exome
AF:
0.234
Gnomad NFE exome
AF:
0.307
Gnomad OTH exome
AF:
0.243
GnomAD4 exome
AF:
0.271
AC:
391396
AN:
1444386
Hom.:
58769
Cov.:
27
AF XY:
0.267
AC XY:
191525
AN XY:
718562
show subpopulations
Gnomad4 AFR exome
AF:
0.0417
Gnomad4 AMR exome
AF:
0.199
Gnomad4 ASJ exome
AF:
0.221
Gnomad4 EAS exome
AF:
0.000556
Gnomad4 SAS exome
AF:
0.0804
Gnomad4 FIN exome
AF:
0.246
Gnomad4 NFE exome
AF:
0.310
Gnomad4 OTH exome
AF:
0.233
GnomAD4 genome
AF:
0.201
AC:
30630
AN:
152230
Hom.:
4190
Cov.:
33
AF XY:
0.194
AC XY:
14448
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.0536
Gnomad4 AMR
AF:
0.213
Gnomad4 ASJ
AF:
0.212
Gnomad4 EAS
AF:
0.00174
Gnomad4 SAS
AF:
0.0767
Gnomad4 FIN
AF:
0.230
Gnomad4 NFE
AF:
0.309
Gnomad4 OTH
AF:
0.184
Alfa
AF:
0.280
Hom.:
12028
Bravo
AF:
0.194
TwinsUK
AF:
0.311
AC:
1152
ALSPAC
AF:
0.319
AC:
1230
ESP6500AA
AF:
0.0526
AC:
199
ESP6500EA
AF:
0.304
AC:
2499
ExAC
AF:
0.211
AC:
25492
Asia WGS
AF:
0.0390
AC:
136
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 10, 2012- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 08, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 12, 2013- -
Cardiomyopathy Benign:2
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 26, 2014- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 15, 2018- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Catecholaminergic polymorphic ventricular tachycardia Benign:1
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Arrhythmogenic right ventricular dysplasia 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 09, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.23
Cadd
Benign
22
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.54
D;T
Eigen
Benign
0.088
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.92
D;D
MetaRNN
Benign
0.0016
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.72
N;.
MutationTaster
Benign
0.0042
P
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-3.3
D;.
REVEL
Uncertain
0.41
Sift
Benign
0.47
T;.
Polyphen
0.29
B;.
Vest4
0.36
MPC
0.50
ClinPred
0.050
T
GERP RS
5.7
Varity_R
0.34
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34967813; hg19: chr1-237841390; COSMIC: COSV63683862; API